Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice
Proceedings of the National Academy of Sciences · 30.09.2025 · 122 (39)
DOI: 10.1073/pnas.2422171122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 24.09.2025. Verfasst von Miyu Moriyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510. Hauptthemen laut MEDLINE: Immunity, Mucosal, Influenza Vaccines, Immunization, Secondary, Orthomyxoviridae Infections. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHMI (HHMI), HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Licensed parenteral influenza vaccines induce systemic antibody responses and alleviate disease severity but do not efficiently induce local mucosal immune responses. Here, we describe an intranasal booster strategy with unadjuvanted recombinant hemagglutinin (HA) following initial messenger RNA-lipid nanoparticle (mRNA-LNP) vaccination, Prime and HA. This regimen establishes highly protective HA-specific mucosal immune memory responses in the respiratory tract. Intranasal HA boosters resulted in significantly reduced viral replication compared to parenteral mRNA-LNP boosters in both young and old mice. Correlation analysis revealed that slightly increased levels of nasal Immunoglobulin A (IgA) are significantly associated with a reduced viral burden in the upper respiratory tract. Intranasal boosting with bivalent H1 HA induced mucosal immunity against vaccine-matched and mismatched heterologous influenza viruses. Additionally, a heterosubtypic intranasal H5 HA booster elicited H5-reactive mucosal humoral responses in H1-surviving mice. Our work illustrates the potential of a nasal HA protein booster as an adjuvant-free strategy to prevent infection and disease from influenza A viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510.
- Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06510.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.
- Department of Pathology, Yale University School of Medicine, New Haven, CT 06510.
- Department of Molecular Cellular and Developmental Biology, Yale University, New Haven CT 06511.
- HHMI, Chevy Chase, MD 20815.
ORCID-Profile: Miyu Moriyama, Robert J Homer, Akiko Iwasaki
Förderung
- NIAID NIH HHS
- HHMI (HHMI)
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Moriyama, M., Rodrigues, G., Wang, J., Jayewickreme, R., Hudak, A., Dong, H., Homer, R. J., Ma, S., & Iwasaki, A. (2025). Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice. Proceedings of the National Academy of Sciences, 122(39). https://doi.org/10.1073/pnas.2422171122
Vancouver
Moriyama M, Rodrigues G, Wang J, Jayewickreme R, Hudak A, Dong H, et al. Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice. Proceedings of the National Academy of Sciences. 2025;122(39). doi:10.1073/pnas.2422171122
BibTeX
@article{Moriyama2025,
author = {Moriyama, Miyu and Rodrigues, Gisele and Wang, Jiping and Jayewickreme, Radeesha and Hudak, Andrew and Dong, Huiping and Homer, Robert J and Ma, Shuangge and Iwasaki, Akiko},
title = {Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {39},
doi = {10.1073/pnas.2422171122}
}
EUVIMED